ARTICLE | Clinical News
PI-88: Phase II started
August 15, 2005 7:00 AM UTC
PGL started an Australian Phase II trial in 82 patients to evaluate PI-88 plus Taxotere docetaxel. Taxotere is marketed by sanofi-aventis Group (Euronext:SAN; SNY, Paris, France). ...